IDEAYA Biosciences (IDYA) Other Accumulated Expenses (2018 - 2026)

IDEAYA Biosciences (IDYA) has 9 years of Other Accumulated Expenses data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses fell 95.43% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 95.43% YoY), and the FY2025 full-year result was $1.1 million, down 94.68% from the prior year.
• Other Accumulated Expenses rose to $1.2 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $32.9 million in Q3 2025 to a low of $92000.0 in Q4 2022.
• A 5-year average of $9.2 million and a median of $5.9 million in 2023 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses sank 98.83% in 2022 and jumped 11504.35% in 2023, its largest moves.
• Tracing IDYA's Other Accumulated Expenses over 5 years: stood at $92000.0 in 2022, then jumped by 11504.35% to $10.7 million in 2023, then jumped by 86.92% to $20.0 million in 2024, then sank by 94.68% to $1.1 million in 2025, then advanced by 11.86% to $1.2 million in 2026.
• Business Quant data shows IDYA's Other Accumulated Expenses at $1.2 million in Q1 2026, $1.1 million in Q4 2025, and $32.9 million in Q3 2025.